Skip to main content

Matt Hewitt

Analyst

Craig-Hallum Capital Group

Equibles does not estimate personal net worth.

About Matt Hewitt

Matt Hewitt is recorded as Analyst at Craig-Hallum Capital Group. Matt Hewitt has spoken on 31 earnings calls across 16 companies, most recently for Park Dental Partners, Inc. on August 13, 2026. Those appearances were for Repligen Corp (RGEN), Lifecore Biomedical, Inc. De (LFCR), Inotiv, Inc. (NOTVQ), Maxcyte, Inc. (MXCT), Dyadic International Inc (DYAI) and 11 other companies. The companies whose calls Matt Hewitt spoke on are classified in the Healthcare and Consumer Defensive sectors.

Matt Hewitt on recent calls

“Maybe along those lines, that's a bigger organization, obviously, than you have purchased over the past year. And I'm just curious, with an organization that size added to Park Dental, is that going to give you some leverage from a purchasing standpoint with your vendors?”
Analyst — Craig-Hallum Capital Group, Second Quarter 2026 Earnings Release and Conference Call ·
“I'm curious, regarding the Genentech agreement, how have the discussions with some of your other larger SPL customers changed, if at all?”
Analyst — Craig-Hallum Capital Group, Maxcyte, Inc. Q2 FY2026 Earnings Call ·
“Maybe first up, I think both in your Q as well as in your prepared remarks, you noted fairly significant ordering activity post-closing the Q2 books. I'm just curious, should we anticipate that we're going to see product revenues here in the third quarter?”
Analyst — Craig-Hallum Capital Group, Dyadic International Inc Q2 FY2026 Earnings Call ·
“I guess, first up, it's almost a month since he closes on what transaction. I'm just curious if you found any surprises as you dug in a little more deeply into that portfolio of assets.”
Analyst — Craig-Hallum Capital Group, Ligand Second Quarter 2026 Earnings Call ·
“Maybe first up, congratulations on the record quarter with the new online strategy. I'm just curious how that's kind of playing out relative to your expectations and how we should think about that ramp over the course of this year and the next year.”
Analyst — Craig-Hallum Capital Group, Q2 2026 Maravai LifeSciences Earnings Conference Call ·

Affiliation history

  • Craig-Hallum Capital Group

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 19 earlier activities